Status: Recruiting
Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
First in Human, pilot investigation An Open Label, Monocentric, Pilot Study Evaluating Safety of ExOlin® in Patients with Poorly Controlled Type 1 Diabetes with High Glucose Fluctuations, Prone to Severe Hypoglycemia
Participants needed: 8
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: DefymedUpdated: Jul 27, 2022Locations: 1
Eligibility criteria
Adult men or women (age ≥ 18 years); [+10]
Renal glomerular filtration rate <30 mL/min/1.73m2 as per Chronic Kidney Disease... [+24]